Impact of green tea on obesity-related hormones in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 26

فایل این مقاله در 16 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_AJP-16-5_003

تاریخ نمایه سازی: 17 مهر 1405

چکیده مقاله:

Objective: Menopause leads to hormonal changes that increase visceral fat, raising risks for metabolic disorders and breast cancer due to altered adipocytokine levels. Green tea (Camellia sinensis L.), containing catechins like EGCG (epigallocatechin gallate), may improve metabolic health in postmenopausal women. In this review we assessing the effects of green tea consumption on key obesity related hormones in postmenopausal women.Materials and Methods: This study reviewed randomized controlled trials (RCTs) from PubMed, Science Direct, Cochrane Library, and Google Scholar up to March ۲۰۲۴, focusing on green tea’s effects on leptin, adiponectin, ghrelin, and insulin. Eight RCTs with ۶۳۲ participants were analyzed using standardized mean differences (SMDs) with ۹۵% confidence intervals (CIs) in a random-effects model. Heterogeneity was measured with the I² statistic, and publication bias was assessed via Egger’s test and funnel plots.Results: Green tea significantly reduced ghrelin levels (SMD: -۴.۶۳, ۹۵% CI: -۸.۴۴ to -۰.۸۲, p = ۰.۰۲, I² = ۹۸.۹۸%), particularly at doses >۱۰۰۰ mg/day and durations >۸ weeks. No significant effects were observed for leptin (SMD: -۰.۳۳, ۹۵% CI: -۰.۸۹ to ۰.۲۲, p = ۰.۲۴), adiponectin (SMD: -۰.۵۳, ۹۵% CI: -۱.۴۴ to ۰.۳۹, p = ۰.۲۶), or insulin (SMD: -۰.۸۷, ۹۵% CI: -۴.۳۱ to ۲.۵۸, p = ۰.۶۲). Subgroup analyses revealed significant reductions in leptin at doses >۱۰۰۰ mg/day, durations ≤۸ weeks, and BMI <۲۹ kg/m²; adiponectin at ۴۰۰–۱۰۰۰ mg/day and insulin at durations ≤۸ weeks and BMI <۲۹ kg/m². High heterogeneity and some evidence of publication bias were noted. Conclusion: Green tea notably reduced ghrelin, with context-specific effects on leptin, adiponectin, and insulin based on dose, duration, and body mass index (BMI), suggesting tailored benefits for postmenopausal women’s metabolic health.

کلیدواژه ها:

نویسندگان

Sahar Ghoflchi

Mashhad University of Medical Sciences, Mashhad, Iran.

Hossein Hosseini

Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Sajad Rafiee

Department of Clinical Biochemistry, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Ghader Babaei

Department of Clinical Biochemistry, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran

Majid Effati

Mashhad University of Medical Sciences, Mashhad, Iran.

Mahdieh Aliyari

Mashhad University of Medical Sciences, Mashhad, Iran.

Reyhane Ghayour vatanparast

Mashhad University of Medical Sciences, Mashhad, Iran.

Masoud Imani

Department of Biostatistics, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.

Masoumeh Rajabibazl

Department of Clinical Biochemistry, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.